Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Expansion of Prior Existing TP53 Mutated Clones in Polycythemia Vera Patients Treated with Idasanutlin

Bridget Marcellino, MD PhD, Bruno Cassinat, PharmD, PhD, Noushin Farnoud, PhD, Min Lu, PhD, Emmanuelle Verger, PhD, Erin McGovern, BA, Minal A Patel, MPH, Heidi E. Kosiorek, MS, Meenakshi Mehrotra, PhD, Jane Houldsworth, PhD, Amylou C. Dueck, PhD, Michael Rossi, PhD, Jean-Jacques Kiladjian, MD PhD, Raajit K. Rampal, MD PhD, John Mascarenhas, MD, Ronald Hoffman, MD

Blood (2019) 134 (Supplement_1): 838.

https://doi.org/10.1182/blood-2019-128342

Published: 2019

Journal Articles

A Novel Combination of Drugs Which Target Both the Intrinsic and Extrinsic Apoptotic Pathways to Eliminate Myelofibrosis CD34+ Cells

Min Lu, PhD, Lijuan Xia, Ronald Hoffman, MD

Blood (2019) 134 (Supplement_1): 4201.

https://doi.org/10.1182/blood-2019-129017

Published: 2019

Journal Articles

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

Bridget Marcellino, MD PhD, Joseph Tripodi, Michal Bar-Natan, MD, Harry Fruchtman, Noushin Farnoud, PhD, Min Lu, PhD, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Raajit K. Rampal, MD PhD, John Mascarenhas, MD, Vesna Najfeld, PhD, Ronald Hoffman, MD

Blood (2019) 134 (Supplement_1): 4207.

https://doi.org/10.1182/blood-2019-129565

Published: 2019

Journal Articles

Enriched Populations of Human Megakaryocytic Cells Affect the Behavior of Myelofibrosis CD34+ Cells As Well As Cells Belonging to the MF Supportive Microenvironment

Min Lu, PhD MD, Lijuan Xia, Mohamed E. Salama, MD, Ronald Hoffman, MD

Blood (2018) 132 (Supplement 1): 3057.

https://doi.org/10.1182/blood-2018-99-117062

Published: 2018

Journal Articles

Splenic Micro Environmental Cells from Patients with Myelofibrosis Elaborate a Cascade of Cytokines and Serve As a Niche for Malignant Hematopoiesis

Min Lu, PhD MD, Lijuan Xia, Mohamed E Salama, MD, Ronald Hoffman, MD

Blood (2016) 128 (22): 953.

https://doi.org/10.1182/blood.V128.22.953.953

Published: 2016

Journal Articles

The Effects of Lipocalin (LCN2) on Hematopoiesis in Primary Myelofibrosis

Min Lu, PhD MD, Lijuan Xia, Yen-Chun Liu, Tsivia Hochman, Rona Singer Weinberg, PhD, Judith D Goldberg, Ronald Hoffman

Blood (2014) 124 (21): 1878.

https://doi.org/10.1182/blood.V124.21.1878.1878

Published: 2014

Journal Articles

Neutophil Gelatinase –Associated Lipocalin (LCN2) Affects Primary Melofibrosis Hematopoietic Progenitor Cells As Well As Microenvironmental Cells

Min Lu, PhD, Lijuan Xia, Rona Singer Weinberg, PhD, Ronald Hoffman, MD

Blood (2013) 122 (21): 2839.

https://doi.org/10.1182/blood.V122.21.2839.2839

Published: 2013

Journal Articles

Interferon α Has Varied Effects On CD34 + Cells From Patients With Polycythemia Vera

Min Lu, PhD, Seungyeul Yoo, Lijuan Xia, Xiaoli Wang, Yan Li, Jun Zhu, Ronald Hoffman, MD

Blood (2013) 122 (21): 2840.

https://doi.org/10.1182/blood.V122.21.2840.2840

Published: 2013

Journal Articles

Characterization Of Splenic Fibroblasts From Patients With Myelofibrosis

Xiaoli Wang, Joseph Tripodi, MS, Vesna Najfeld, PhD, Min Lu, PhD, Ronald Hoffman, MD

Blood (2013) 122 (21): 4107.

https://doi.org/10.1182/blood.V122.21.4107.4107

Published: 2013

Journal Articles

Combination Treatment with RG7112 and Pegylated Interferon α 2a Specifically Targets JAK2V617F Positive Progenitor Cells From Patients with Myeloproliferative Neoplasms.

Min Lu, PhD., Xiaoli Wang, MD, PhD, Goar Mosoyan, Yan Li, Ronald Hoffman, MD

Blood (2012) 120 (21): 2865.

https://doi.org/10.1182/blood.V120.21.2865.2865

Published: 2012

Journal Articles

JAK2 Inhibitors Do Not Affect Stem Cells Present in the Spleens of Patients with Myelofibrosis

Xiaoli Wang, MD, PhD, Joseph Tripodi, MS, Jesse Novak, Min Lu, PhD., Yan Li, Vesna Najfeld, Ph.D, Ronald Hoffman, MD

Blood (2012) 120 (21): 1752.

https://doi.org/10.1182/blood.V120.21.1752.1752

Published: 2012

Journal Articles

Prolonged Low Dose Therapy with a Pan-Deacetylase Inhibtor, Panobinostat (LBH589), in Patients with Myelofibrosis

John Mascarenhas, MD, Alice Mercado, RN, Amelyn Rodriguez, BSN, RN, OCN, Min Lu, PhD, Carla Kalvin, Xiaochun Li, PhD, Bruce Petersen, MD, Vesna Najfeld, PhD, Judith D. Goldberg, Sc.D., Ronald Hoffman, MD

Blood (2011) 118 (21): 794.

https://doi.org/10.1182/blood.V118.21.794.794

Published: 2011

Journal Articles

Treatment with Nutlin-3, a Small-Molecule Antagonist of MDM2, in Combination with Low Doses of Pegylated Interferon Alpha 2a Targets Hematopoietic Progenitor Cells From Polycythemia Vera (PV) Patients

Min Lu, PhD, Joseph Tripodi, MS, Yan Li, Xiaoli Wang, MD, PhD, Vesna Najfeld, PhD, John Mascarenhas, MD, Ronald Hoffman, MD

Blood (2011) 118 (21): 796.

https://doi.org/10.1182/blood.V118.21.796.796

Published: 2011

Journal Articles

Characterization of Splenic CD34 + Cells From Patients with Primary Myelofibrosis

Xiaoli Wang, MD, PhD, Sonam Prakash, Min Lu, PhD, Yan Li, Attilio Orazi, MD, Ronald Hoffman, MD

Blood (2011) 118 (21): 2810.

https://doi.org/10.1182/blood.V118.21.2810.2810

Published: 2011

Journal Articles

Treatment in Vitro with a Combination of Bcl-Xl Inhibitor-ABT-737 and a JAK2 Inhibitor Selectively Eliminates JAK2V617F MPN Progenitor Cells.

Min Lu, PhD, Wei Zhang, Jiapeng Wang, Yan Li, Xiaoli Wang, MD, PhD, Daniel Yoo, Adam Austin, John Mascarenhas, MD, Zhizhuang Joe Zhao, Ronald Hoffman, MD, Mingjiang Xu, MD, PhD

Blood (2009) 114 (22): 752.

https://doi.org/10.1182/blood.V114.22.752.752

Published: 2009

Journal Articles

Treatment with Pegylated Interferon Alpha 2a in Combination with the Bcl-Xl Inhibitor ABT-737 Specifically Targets JAK2V617F Positive Hematopoietic Progenitor Cells From Patients with Polycythemia Vera.

Min Lu, PhD, Wei Zhang, Daniel Yoo, Dmitriy Berenzon, Yan Li, Xiaoli Wang, MD, PhD, Adam Austin, John Mascarenhas, MD, Mingjiang Xu, MD, PhD, Ronald Hoffman, MD

Blood (2009) 114 (22): 3916.

https://doi.org/10.1182/blood.V114.22.3916.3916

Published: 2009

NARROW

Expansion of Prior Existing TP53 Mutated Clones in Polycythemia Vera Patients Treated with Idasanutlin

A Novel Combination of Drugs Which Target Both the Intrinsic and Extrinsic Apoptotic Pathways to Eliminate Myelofibrosis CD34+ Cells

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

Enriched Populations of Human Megakaryocytic Cells Affect the Behavior of Myelofibrosis CD34+ Cells As Well As Cells Belonging to the MF Supportive Microenvironment

Splenic Micro Environmental Cells from Patients with Myelofibrosis Elaborate a Cascade of Cytokines and Serve As a Niche for Malignant Hematopoiesis

The Effects of Lipocalin (LCN2) on Hematopoiesis in Primary Myelofibrosis

Neutophil Gelatinase –Associated Lipocalin (LCN2) Affects Primary Melofibrosis Hematopoietic Progenitor Cells As Well As Microenvironmental Cells

Interferon α Has Varied Effects On CD34 + Cells From Patients With Polycythemia Vera

Characterization Of Splenic Fibroblasts From Patients With Myelofibrosis

Combination Treatment with RG7112 and Pegylated Interferon α 2a Specifically Targets JAK2V617F Positive Progenitor Cells From Patients with Myeloproliferative Neoplasms.

JAK2 Inhibitors Do Not Affect Stem Cells Present in the Spleens of Patients with Myelofibrosis

Prolonged Low Dose Therapy with a Pan-Deacetylase Inhibtor, Panobinostat (LBH589), in Patients with Myelofibrosis

Treatment with Nutlin-3, a Small-Molecule Antagonist of MDM2, in Combination with Low Doses of Pegylated Interferon Alpha 2a Targets Hematopoietic Progenitor Cells From Polycythemia Vera (PV) Patients

Characterization of Splenic CD34 + Cells From Patients with Primary Myelofibrosis

Treatment in Vitro with a Combination of Bcl-Xl Inhibitor-ABT-737 and a JAK2 Inhibitor Selectively Eliminates JAK2V617F MPN Progenitor Cells.

Treatment with Pegylated Interferon Alpha 2a in Combination with the Bcl-Xl Inhibitor ABT-737 Specifically Targets JAK2V617F Positive Hematopoietic Progenitor Cells From Patients with Polycythemia Vera.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only